Skip to search formSkip to main contentSkip to account menu

Cardiotoxicity

Known as: Cardiac Toxicities, Toxicity, Cardiac, Cardiac Toxicity 
Toxicity that impairs or damages the heart. This condition is often caused by the administration of a pharmaceutical agent that initiates a poisonous… 
National Institutes of Health

Related topics

Related topics

4 relations
In BloodMicrobiologicalnursing therapyprevention & control

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2003
Review
2003
Immunotherapy as part of combinations for the treatment of cancer.
Highly Cited
2002
Highly Cited
2002
Phase II trial of weekly vinorelbine and trastuzumab as first-line therapy in patients with HER2(+) metastatic breast cancer.
PURPOSE Human epidermal growth factor receptor 2 (HER2) overexpression is associated with a more aggressive form of breast cancer… 
Highly Cited
1999
Highly Cited
1999
Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: a phase II randomized study of the Southern Italy Cooperative Oncology Group.
PURPOSE In a previous phase I study cisplatin (CDDP), gemcitabine (GEM), and vinorelbine (VNR) combination therapy was safe and… 
Highly Cited
1996
Highly Cited
1996
Phase II study of paclitaxel in patients with recurrent malignant glioma.
PURPOSE To assess the efficacy and toxicity of paclitaxel administered as a 3-hour infusion to patients with recurrent malignant… 
Highly Cited
1994
Highly Cited
1994
Phase II study on neoadjuvant hyperthermic‐antiblastic perfusion with doxorubicin in patients with intermediate or high grade limb sarcomas
Background. Locoregional control of soft tissue sarcomas of the limbs is achieved generally using a multidisciplinary approach… 
Highly Cited
1985
Highly Cited
1985
Phase I study of vinblastine and verapamil given by concurrent iv infusion.
Overcoming resistance to chemotherapy is an important goal in cancer treatment. In many systems, resistance to anthracyclines and… 
Highly Cited
1983
Highly Cited
1983
Phase I and clinical pharmacology studies of intravenous and oral administration of 4-demethoxydaunorubicin in patients with advanced cancer.
4-Demethoxydaunorubicin (4-DMDR), an anthracycline analogue available in i.v. and p.o. form, has shown significant antitumor… 
Highly Cited
1977
Highly Cited
1977
Experience with the use of adriamycin in combination with other anticancer agents using a weekly schedule, with particular reference to lack of cardiac toxicity
Two hundred and seven patients have been treated using a weekly regimen of Adriamycin in combination with various other… 
Highly Cited
1974
Highly Cited
1974
Accelerated cardiac escape rhythms caused by ouabain intoxication.
Highly Cited
1972
Highly Cited
1972
Cellular immunity to human breast carcinoma
An in vitro microassay technique was used to study the cellular immunological response of 16 breast carcinoma patients against… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)